Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Shah

Showing results (441-450 of 498) with videos related to

Pageof 50
Sort By:
The Journal of Urology|April 4, 2023
Evaluation of Outcomes Following Focal Ablative Therapy for Treatment of Localized Clinically Significant Prostate Cancer in Patients >70 Years: A Multi-institute, Multi-energy 15-Year ExperienceDavid Habashy, Deepika Reddy, Max Peters, et al.
European Urology Oncology|June 14, 2025
Combination Cytoreductive Surgery, Radiotherapy, or Ablation for De Novo Metastatic Prostate Cancer: The IP2-ATLANTA Internal Pilot, Phase 2, Randomised Controlled TrialMartin J Connor, Taimur T Shah, Johanna Sukumar, et al.
Cancer Discovery|September 30, 2018
Genome-Informed Targeted Therapy for OsteosarcomaLeanne C Sayles, Marcus R Breese, Amanda L Koehne, et al.
Actas Urologicas Espanolas|August 13, 2023
Prevalence of urinary tract cancer in the Spanish cohort of the IDENTIFY studyC Toribio-Vázquez, J Gómez Rivas, F Amigo, et al.
Prostate Cancer and Prostatic Diseases|May 2, 2021
Conventional radical versus focal treatment for localised prostate cancer: a propensity score weighted comparison of 6-year tumour controlMarieke J van Son, Max Peters, Deepika Reddy, et al.
European Urology|October 1, 2023
The Role of Multiparametric MRI and MRI-targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST TrialAlexander Light, Abi Kanthabalan, Marjorie Otieno, et al.
JAMA Oncology|June 11, 2026
Prostate Imaging Standards for Screening Magnetic Resonance Imaging (PRISM): International Consensus RecommendationsNikhil Mayor, Alexander Light, Archana Gopalakrishnan, et al.
European Urology|July 10, 2026
Oncological Outcomes Following Focal HIFU and Cryotherapy for Treatment of Nonmetastatic Prostate Cancer in the United Kingdom: An Updated Analysis of 3477 Patients from the Prospective HEAT and ICE RegistriesAlexander Light, Max Peters, Archana Gopalakrishnan, et al.
European Urology|April 4, 2022
Magnetic Resonance Imaging and Targeted Biopsies Compared to Transperineal Mapping Biopsies Before Focal Ablation in Localised and Metastatic Recurrent Prostate Cancer After RadiotherapyTaimur T Shah, Abi Kanthabalan, Marjorie Otieno, et al.
European Urology|February 6, 2022
Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year ExperienceDeepika Reddy, Max Peters, Taimur T Shah, et al.
Pageof 50

Showing results (441-450 of 498) with videos related to

Sort By:
Pageof 50
The Journal of Urology|April 4, 2023
Evaluation of Outcomes Following Focal Ablative Therapy for Treatment of Localized Clinically Significant Prostate Cancer in Patients >70 Years: A Multi-institute, Multi-energy 15-Year ExperienceDavid Habashy, Deepika Reddy, Max Peters, et al.
European Urology Oncology|June 14, 2025
Combination Cytoreductive Surgery, Radiotherapy, or Ablation for De Novo Metastatic Prostate Cancer: The IP2-ATLANTA Internal Pilot, Phase 2, Randomised Controlled TrialMartin J Connor, Taimur T Shah, Johanna Sukumar, et al.
Cancer Discovery|September 30, 2018
Genome-Informed Targeted Therapy for OsteosarcomaLeanne C Sayles, Marcus R Breese, Amanda L Koehne, et al.
Actas Urologicas Espanolas|August 13, 2023
Prevalence of urinary tract cancer in the Spanish cohort of the IDENTIFY studyC Toribio-Vázquez, J Gómez Rivas, F Amigo, et al.
Prostate Cancer and Prostatic Diseases|May 2, 2021
Conventional radical versus focal treatment for localised prostate cancer: a propensity score weighted comparison of 6-year tumour controlMarieke J van Son, Max Peters, Deepika Reddy, et al.
European Urology|October 1, 2023
The Role of Multiparametric MRI and MRI-targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST TrialAlexander Light, Abi Kanthabalan, Marjorie Otieno, et al.
JAMA Oncology|June 11, 2026
Prostate Imaging Standards for Screening Magnetic Resonance Imaging (PRISM): International Consensus RecommendationsNikhil Mayor, Alexander Light, Archana Gopalakrishnan, et al.
European Urology|July 10, 2026
Oncological Outcomes Following Focal HIFU and Cryotherapy for Treatment of Nonmetastatic Prostate Cancer in the United Kingdom: An Updated Analysis of 3477 Patients from the Prospective HEAT and ICE RegistriesAlexander Light, Max Peters, Archana Gopalakrishnan, et al.
European Urology|April 4, 2022
Magnetic Resonance Imaging and Targeted Biopsies Compared to Transperineal Mapping Biopsies Before Focal Ablation in Localised and Metastatic Recurrent Prostate Cancer After RadiotherapyTaimur T Shah, Abi Kanthabalan, Marjorie Otieno, et al.
European Urology|February 6, 2022
Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year ExperienceDeepika Reddy, Max Peters, Taimur T Shah, et al.
Pageof 50